APPLICATION
ANDA073310
TYPE
ANDA
ORIGINAL APPROVAL
1991-11-27
LATEST ACTION
2016-05-09
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued
Products
TOLMETIN SODIUMDiscontinued
TOLMETIN SODIUM EQ 200MG BASE · TABLET · ORAL
Approval history
2016-05-09Labeling · Supplement 22 · standardAP
2008-04-03Labeling · Supplement 19AP
2006-05-16Labeling · Supplement 18AP
2002-06-14Manufacturing (CMC) · Supplement 7AP
2000-05-16Manufacturing (CMC) · Supplement 5AP
2000-05-16Manufacturing (CMC) · Supplement 6AP
1997-12-05Manufacturing (CMC) · Supplement 4AP
1997-02-24Manufacturing (CMC) · Supplement 3AP
1995-06-22Manufacturing (CMC) · Supplement 2AP
1994-01-12Manufacturing (CMC) · Supplement 1AP
1991-11-27OriginalAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.